By otakuyassine3@gmail.com 
Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 4,400,000 shares, an increase of 18.9% from the December 31st total of 3,700,000 shares. Based on an average daily trading volume, of 1,320,000 shares, the short-interest ratio is currently 3.3 days.
Intuitive Surgical Stock Performance
Intuitive Surgical stock traded down $8.30 during midday trading on Friday, reaching $571.88. The stock had a trading volume of 1,825,083 shares, compared to its average volume of 1,817,004. The stock has a market capitalization of $203.69 billion, a PE ratio of 89.22, a price-to-earnings-growth ratio of 5.52 and a beta of 1.39. Intuitive Surgical has a twelve month low of $364.17 and a twelve month high of $616.00. The stock’s 50-day simple moving average is $550.40 and its 200 day simple moving average is $509.43.
Insider Buying and Selling at Intuitive Surgical
In other news, insider Jamie Samath sold 269 shares of the business’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 28,843 shares of company stock valued at $15,357,560. Insiders own 0.90% of the company’s stock.
Hedge Funds Weigh In On Intuitive Surgical
Several institutional investors and hedge funds have recently made changes to their positions in the business. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. increased its stake in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the third quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $36,000. Finally, Sierra Ocean LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth $40,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Bernstein Bank boosted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $613.10.
Get Our Latest Research Report on Intuitive Surgical
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
Receive News & Ratings for Intuitive Surgical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Intuitive Surgical and related companies with MarketBeat.com’s FREE daily email newsletter.